Why the study?
CVDs are the leading cause of mortality in China, and precise CVD risk identification is fundamental to primary prevention.
How do cardiovascular disease risk prediction models perform in the Chinese population?
How do cardiovascular disease risk prediction models perform in the Chinese population?
Several CVD risk prediction models have been developed or validated in the Chinese population, with China-PAR showing good calibration, though further external validation is needed.
Answers are grounded in this paper and cite their sources.
Acceptable model performance supports risk stratification in Chinese adults; extends validation data but leaves prospective impact open.
Background: There is an increasing prevalence of CVDs in China which represented the top leading cause of mortality. It is critical to know that precise CVDs risk identification is the fundamental prevention component. This study sought to systematically review the Cardiovascular disease (CVDs) risk prediction models derived and(or) validated in Chinese population to promote CVD primary prevention. Methods: Reports were included if they derived or validated one or more CVDs risk prediction models in the Chinese. Pubmed, Embase, CINAHL, Web of Science, Scopus, China National Knowledge Infrastructure (CNKI), VIP database et al. were searched. Risk of bias was conducted with PROBAST (Prediction model Risk of Bias Assessment Tool). Meta-analysis was performed in R using the package metamisc. Results: From 55183 records, 22 studies were included. Twelve studies derived 18 CVDs risk prediction models, of which seven models were derived based on multicenter cohort including more than two provinces of mainland China, one was model developed based on New Zealand cohort including Chinese. The number of predictors was from 6 to 22. The definitions of predicted outcomes showed considerable heterogeneity. Fourteen articles described 29 validations of 8 models. The Framingham model, the Pooled Cohorts Equations (PCEs) were the most frequently validated foreign tools. Discrimination was acceptable and similar for males and females among models (0.60-0.83). Calibration estimates changed substantially from one population to another. China-PAR showed good calibration [Observed/Expected events ratio=0.99, 95%PI (0.57,1.70)] and female [1.10, 95%PI (0.23,5.16)]. Conclusions: Several models developed or validated in Chinese population. The usefulness of most of the models remains unclear due to incomplete external validation and head-to-head comparison. Future research should focus on externally validating or tailoring these models to local settings.Trail registration: This systematic review was registered at PROSPERO (International Prospective Register of Systematic Reviews, CRD42021277453).
No takes yet. Share an insight, caveat, or question.
Zhiting et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: